✅ Moderna wins European patent case in Pfizer, BioNTech dispute, FT reports - TipRanks.com - TipRanks

Moderna (MRNA) has won a case against Pfizer (PFE) and BioNTech (BNTX) at the European Patent Office in its ongoing legal dispute to recoup pandemic profits, The Financial Times’ Oliver Barnes and Ian Johnston reports. The EPO’s Opposition Division ruled to uphold the validity of one of two disputed patents, according to the report. “We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna’s EP949 patent, one of the key patents currently asserted against Pfizer and BioNTech in various European national courts,” Moderna told the publication, which notes that Pfizer has a nine-month window to lodge an appeal, which it said it may do.

tipranks.com     May 18, 2024